Skip Therapeutics

Skip Therapeutics is a pioneering force in biotechnology research, dedicated to developing innovative RNA-based therapies for both rare genetic disorders and prevalent diseases. Skip Therapeutics integrates cutting-edge computational and experimental methodologies to optimize target selection and therapeutic design, ensuring precision and efficacy in its approach.

Located at 2 Ilan Ramon St., Ness Ziona, 7403635, IL, Skip Therapeutics utilizes sequence-based molecules, specifically Antisense Oligonucleotides (ASOs), to restore the function of mutated genes in rare genetic disorders. Moreover, the company adeptly modifies the functionality of key genes within major disease pathways, showcasing its commitment to addressing a wide spectrum of medical needs.

The convergence of Skip Therapeutics' novel computational discovery engine and robust experimental capabilities positions the company as a unique and impactful venture in the RNA-based therapy landscape. Skip Therapeutics is poised to revolutionize treatment options and improve patient outcomes globally. We invite the manager of Skip Therapeutics to create a customized and exclusive company showcase and product listing on our platform.